Management of Brain Cancer and Neurodegenerative Disorders with Polymer-Based Nanoparticles as a Biocompatible Platform
Molecules · 14.01.2023 · 28 (2) · 841
DOI: 10.3390/molecules28020841 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 14.01.2023. Verfasst von Mehdi Bazi Alahri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Psychology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran 1971653313, Iran. Hauptthemen laut MEDLINE: Brain Neoplasms, Nanoparticles, Neurodegenerative Diseases. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 192 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The blood–brain barrier (BBB) serves as a protective barrier for the central nervous system (CNS) against drugs that enter the bloodstream. The BBB is a key clinical barrier in the treatment of CNS illnesses because it restricts drug entry into the brain. To bypass this barrier and release relevant drugs into the brain matrix, nanotechnology-based delivery systems have been developed. Given the unstable nature of NPs, an appropriate amount of a biocompatible polymer coating on NPs is thought to have a key role in reducing cellular cytotoxicity while also boosting stability. Human serum albumin (HSA), poly (lactic-co-glycolic acid) (PLGA), Polylactide (PLA), poly (alkyl cyanoacrylate) (PACA), gelatin, and chitosan are only a few of the significant polymers mentioned. In this review article, we categorized polymer-coated nanoparticles from basic to complex drug delivery systems and discussed their application as novel drug carriers to the brain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Psychology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran 1971653313, Iran.
- Department of Chemistry, Faculty of Science, Al-Hussein Bin Talal University, Ma'an 71111, Jordan.
- Medical Mycology and Bacteriology Research Center, Kerman University of Medical Sciences, Kerman 7616913555, Iran.
- Department of Chemistry, University of Isfahan, Isfahan 8174673441, Iran.
- Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman 7616913555, Iran.
- School of Chemical Engineering, Oklahoma State University, 420 Engineering North, Stillwater, OK 74078, USA.
ORCID-Profile: Mahmood Barani, Hassan Arkaban, Payam Zarrintaj
Zitieren
APA
Bazi Alahri, M., Jibril Ibrahim, A., Barani, M., Arkaban, H., Shadman, S. M., Salarpour, S., Zarrintaj, P., Jaberi, J., & Turki Jalil, A. (2023). Management of Brain Cancer and Neurodegenerative Disorders with Polymer-Based Nanoparticles as a Biocompatible Platform. Molecules, 28(2), 841. https://doi.org/10.3390/molecules28020841
Vancouver
Bazi Alahri M, Jibril Ibrahim A, Barani M, Arkaban H, Shadman SM, Salarpour S, et al. Management of Brain Cancer and Neurodegenerative Disorders with Polymer-Based Nanoparticles as a Biocompatible Platform. Molecules. 2023;28(2):841. doi:10.3390/molecules28020841
BibTeX
@article{BaziAlahri2023,
author = {Bazi Alahri, Mehdi and Jibril Ibrahim, Alhawarin and Barani, Mahmood and Arkaban, Hassan and Shadman, Seyedeh Malahat and Salarpour, Soodeh and Zarrintaj, Payam and Jaberi, Javad and Turki Jalil, Abduladheem},
title = {Management of Brain Cancer and Neurodegenerative Disorders with Polymer-Based Nanoparticles as a Biocompatible Platform},
journal = {Molecules},
year = {2023},
volume = {28},
number = {2},
pages = {841},
doi = {10.3390/molecules28020841}
}
EUVIMED